Skip to main content
Glama

search_failed_bispecifics

Read-onlyIdempotent

Bispecifics that failed at any stage.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
tierNoConfidence tier. 'curated' (default) returns the credible layer; 'all' also includes high-volume screening-grade rows (PubChem HTS inactives, CRISPR non-essential tails).curated
limitNoMaximum number of findings to return (1–100, default 25).
offsetNoNumber of findings to skip before this page, for pagination (default 0).
targetNoUniProt accession or gene symbol
outcomeNooutcome filter (inactive, failed_safety, terminated, …)
compoundNocompound name, ChEMBL ID, or InChIKey

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
findingsNoMatching negative findings (same shape as the REST /findings endpoint).
has_moreNoTrue when more results exist beyond this page.
coverage_noteNoHonest coverage caveat for thin Phase-1 modalities (present only when relevant).
query_metadataYesEcho of the resolved query — tool, limit, offset, and any applied presets.
returned_countNoFindings returned in this page.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • addedInput schema / properties / limit / description
      Added value: +"Maximum number of findings to return (1–100, default 25)."
    • addedInput schema / properties / offset / description
      Added value: +"Number of findings to skip before this page, for pagination (default 0)."
    • changedOutput schema / (root)
      Previous value: -nullNew value: +{
      +  "properties": {
      +    "coverage_note": {
      +      "description": "Honest coverage caveat for thin Phase-1 modalities (present only when relevant).",
      +      "type": "string"
      +    },
      +    "findings": {
      +      "description": "Matching negative findings (same shape as the REST /findings endpoint).",
      +      "items": {
      +        "type": "object"
      +      },
      +      "type": "array"
      +    },
      +    "has_more": {
      +      "description": "True when more results exist beyond this page.",
      +      "type": "boolean"
      +    },
      +    "query_metadata": {
      +      "description": "Echo of the resolved query — tool, limit, offset, and any applied presets.",
      +      "type": "object"
      +    },
      +    "returned_count": {
      +      "description": "Findings returned in this page.",
      +      "type": "integer"
      +    }
      +  },
      +  "required": [
      +    "query_metadata"
      +  ],
      +  "type": "object"
      +}
  2. First observed

TDQS

B3.1/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds the scope 'at any stage,' which is a mild behavioral trait, but no further context about result semantics, open-world caveats, or pagination is disclosed.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, front-loaded sentence with no wasted words. It is efficient, though it could include more substance without sacrificing conciseness.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness2/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having a rich schema, annotations, and output schema, the description is too thin for the tool's context. With over 30 siblings, it does not clarify what 'failed at any stage' encompasses (e.g., clinical stages vs. preclinical), how it overlaps with search_bispecific_format_failures, or other important selection criteria.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, with all six parameters documented including defaults, ranges, and the tier enum. The description adds no parameter-level meaning beyond what the schema already provides, so the baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description 'Bispecifics that failed at any stage' clearly identifies the resource (bispecifics) and the state (failed at any stage), aligning with the tool's name. However, it lacks an explicit verb and does not differentiate this from sibling tools like search_bispecific_format_failures.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

No guidance is given on when to use this tool versus alternatives. With many similar sibling tools (e.g., search_bispecific_format_failures, search_failed_clinical_antibodies), the description provides no selection criteria or exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources